are glp 1 compounds safe IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Decoding GLP-1 Weight Loss Medications

This places TB-500 in the same regulatory category as other research peptides like Ipamorelin and BPC-157 compounds with published preclinical research but no regulatory pathway to market

The pattern of results, particularly the amplification of benefit at higher weight loss thresholds, is consistent with the hypothesis that HRT restores a metabolic environment that makes GLP-1 therapy more effective: improving insulin sensitivity, preserving lean mass, reducing the inflammatory burden that blunts metabolic responsiveness, and supporting the mitochondrial function that underlies energy regulation

Anecdotally, Taylor has heard complaints from people linking their grey-market peptide use to rashes, numbness and mood shifts

The clock starts ticking immediately